BTSG · BrightSpring Health Services
AI read · Good for BTSG
The AI's read
This gives BrightSpring a more favorable outside view. But an analyst's opinion is not proof that the company's sales or profit improved.
Leerink Partners keeps its 'Outperform' rating for BrightSpring Health and raises its price target to $92.
Good for BTSG
Leerink kept its Outperform rating and raised its target from $72 to $92, a favorable view of BrightSpring. It is an analyst's opinion, not proof that the company's business improved.
Get alerts for BTSG
Follow BrightSpring Health Services (BTSG) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BTSGFree on the App Store and Google Play, or on the web.